droplet microfluidics
Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech
The company, formerly called Droplet Genomics, will apply the funds to establish a US customer support team and to advance commercialization of its droplet-based platforms.
The method is available as a service from Single Cell Discoveries, and the researchers behind it are exploring several avenues of commercialization.
Droplet Genomics Debuts New Microfluidic Screening Platform, Touting Throughput, Flexibility
Premium
The Vilnius, Lithuania-based firm recently delivered its first instruments to customers, who are using it for a wide variety of applications.
The European Union has backed the project, called Droplet-Small-Seq, with a €146,000 Horizon 2020 research grant.
US Appeals Court Rejects Bio-Rad's 'Zombie' Claims to 10x Genomics' Single-Cell Patents
The ruling came as part of a decision to uphold a US International Trade Commission finding that Bio-Rad imported and sold infringing products.